Cardiometabolic health encompasses cardiovascular and metabolic diseases, including type 2 diabetes and metabolic syndrome. Collectively, such conditions are the leading cause of preventable death worldwide and people with severe mental illness show a greater cardiometabolic risk than the general population. They are also at a higher risk of developing conditions such as Type 2 diabetes, high blood pressure and blood lipids.
This e-Learning explains the role all pharmacy professionals play in minimising physical health risks to people prescribed antipsychotics, covering the role of antipsychotic treatment in the management of severe mental illness, how they work and common side-effects.
The physical health risks posed by antipsychotics are illustrated, and the importance of adopting patient specific, holistic approaches to physical healthcare monitoring for people prescribed antipsychotics emphasised.
Varying interventions are introduced and the differences in approaches and management strategies between specialist mental health services and non-mental health services are also covered.